Dacetuzumab (Anti-TNFRSF5 / CD40)
Dacetuzumab (Anti-TNFRSF5 / CD40) (A2636-GRP)
Products
Description
Dacetuzumab (Anti-TNFRSF5 / CD40) is a humanized IgG1, monoclonal antibody targeting CD40. Ithas anti-lymphoma activity and can be used for multiple myeloma research. MW :150 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2636 |
| Target | CD markers |